AG NPP709 is presently on the market; however, no research has investigated the result of AG NPP709 in sufferers with COPD. Thus, the purpose of the study was To judge the efficacy of AG NPP709 in people with Long-term bronchitis type COPD. Berberine suppresses inflammatory agents-induced interleukin-1beta and tumor https://shana975tzh0.wikikarts.com/user